BRIEF-Pharma Mar starts phase I trial in Japan for anti-tumor compound PM1183

* Starts phase I trial in Japan for its compound PM1183 for solid tumors Further company coverage: (Gdynia Newsroom)

from Reuters: Healthcare http://ift.tt/2g9Ag48
via IFTTT